Turn on cookies to sign in
Signing in saves your progress to your Curie account. We can only do that with cookies on — turn them on to continue.

A new Medicare pilot program requiring prior authorization for 41 services has led to a notable drop in utilization — but questions remain about whether the care being skipped was truly unnecessary. Published in JAMA, the study found a 15% reduction in epidural steroid injections and a 19.5% drop in other targeted services in participating states. Researchers say the big unanswered question is whether patients are avoiding wasteful care or going without needed treatment.
A Medicare pilot program designed to curb fraud, waste, and abuse is doing what it set out to do — reduce service use. But researchers aren't yet sure if that's a good thing. The Wasteful and Inappropriate Service Reduction (WISeR) model, which requires prior authorization for 41 services and encourages AI in the approval process, was associated with significant drops in utilization in the six states where it launched, according to a research letter published in JAMA.
The study drew on more than 310 million patient records across 2,198+ hospitals and 49,300+ clinics, comparing WISeR states to non-participating states over a two-year pre-launch period versus six months post-launch (January–June 2026).
By the Numbers:
Why it matters: Prior authorization is one of healthcare's most debated tools — it can prevent unnecessary spending, but it can also delay or deny legitimate care. This study shows WISeR is moving the needle on utilization, but without knowing whether the reduced care was wasteful or medically necessary, policymakers face a critical blind spot in evaluating the program's true impact.